General approach to peripheral arterial disease Flashcards

1
Q

Peripheral ARTERIAL disease

A

= disease of all arteries outside of coronary arteries and aorta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Peripheral ARTERY disease

A

= disease of lower extremities

LEAD: lower extremity arterial disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Prognostic clinical signs

A

Individuals with carotid bruits have twice the risk of MI and CV death as compared with those without.

Interarm blood pressure (BP) asymmetry (>15mmHg) is a marker of vascular disease risk and death

A femoral bruit is an independent marker for ischaemic cardiac events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Technique for measuring ABPI

A

Supine position

Place manual blood pressure cuff at ankle after 5-10 minutes of rest

Use doppler probe 5-10MHz

Use handheld doppler to find signal at anterior tibial and then posterior tibial

Inflate the cuff until signal is lost, slowly deflate cuff until signal returns - record as systolic BP

Divide brachial pressure by ankle pressure = ABPI

For lower extremity arterial disease, take the LOWEST value of the two legs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indications for ABPI

A

Patients with clinical suspicion of LEAD

e. g. abolition of pulse
e. g. arterial bruit in lower limb
e. g. typical history of intermittent claudication
e. g. non-healing lower limb wound

Patients AT-RISK of LEAD, i.e. the following conditions:

  • Any other atheroscleortic disease e.g. coronary artery disease
  • Screen heart failure patients
  • AAA
  • CKD

Asymptomatic patients that are AT-RISK for the following reasons:

  • Age >65 years old
  • High-risk of CVD as per ESC guidelines
  • Age >50 with family history of LEAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Value of ABPI

A

The ABI is a non-invasive tool useful for the diagnosis and surveillance of LEAD

Strong marker of generalized atherosclerosis and CV risk
-An ABPI <0.90 is associated with 2-3 fold increase in CV related death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Duplex

A

Duplex ultrasound is a non-invasive imaging modality that uses:

  • b-mode echography
  • pulsed wave, continuous, colour doppler

Allows detection and localisation of vascular lesions and assessment of the severity of stenosis through flow velocity measurement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When to use digital subtraction angiography

A

Classically considered gold standard investigation but largely replaced by non-invasive imaging modalities such as CT angiogram and duplex ultrasound

Still has a place in below-the-knee vessel investigation and when direct intervention planned

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Advantages and disadvantages of CT angiogram

A

Advantages:

  • rapid non-invasive acquisition
  • wide availability
  • high resolution and 3D reformatting.
  • less artefact with movement and respiration
  • able to delineate intraluminal and extraluminal features i.e. aneurysm sac
  • displays a ‘roadmap’ of the vascularization, essential for determining interventional strategies

Disadvantages

  • lack of functional and haemodynamic data
  • radiation exposure
  • uses iodinated contrast which is nephrotoxic and some patients have anaphylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Advantages and disadvantages of magnetic resonance angiography

A

Advantages:

  • valuable in patients with mild-to-moderate CKD
  • good soft tissue imaging
  • does not require iodinated contrast

Disadvantages

  • nephrogenic systemic fibrosis post gadolinium is more common than firs t appreciated, renal function at time of scan important
  • movement artefact
  • lack of availability
  • contraindications include non-compatible pacemakers and implantable cardioverter defibrillators
  • underestimates vascular calcification
  • cannot evaluate endovascular stents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lipid lowering aims in peripheral arterial disease

A

Give statin and aim for

-LDL cholesterol <1.8mmol/L

OR

> 50% reduction in LDL cholesterol if original levels 1.8 - 3.5 mmol/L

Benefits

  • Reduced mortality
  • Reduces stroke risk
  • Reduced CV events

Combination treatment with ezetimibe in selected patients is also beneficial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Blood pressure control in peripheral arterial disease

A

Aim for <140/90 mmHg

In diabetics, aim <140/85 mmHg

ACE-inhibitors and angiotensin receptor blockers have further benefits and should be used
-decrease MACE

B-blockers are safe to use in LEAD unless chronic limb-threatening ischaemia present

Don’t over-treat BP, outcomes are worse in LEAD if BP <110 (j-shaped relationship)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Overview of best medical therapy

A

Smoking cessation is recommended in all patients with PADs - grade IB

Healthy diet and physical activity are recommended for all patients with PADs. - grade IC

Statins are recommended in all patients with PADs. - grade IA

In patients with PADs, it is recommended to reduce LDL-C to < 1.8 mmol/L (70 mg/dL) or decrease it by >_ 50% if baseline values are 1.8–3.5 mmol/L (70–135 mg/dL) - grade IC

In diabetic patients with PADs, strict glycaemic control is recommended.- grade IC

Antiplatelet therapy is recommended in patients with symptomatic PADs - grade IC

In patients with PADs and hypertension, it is recommended to control blood pressure at < 140/90 mmHg.-grade IA

ACEIs or ARBs should be considered as first-line therapyc in patients with PADs and hypertension - grade IIaC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly